recent publications

• academic article

  • Provan, D., Stasi, R., Newland, A. C., Blanchette, V. S., Bolton-Maggs, P., Bussel, J. B., Chong, B. H., Cines, D. B., Gernsheimer, T. B., Godeau, B., Grainger, J., Greer, I., et al. International consensus report on the investigation and management of primary immune thrombocytopenia Blood  2010 115:168-186  DOI:10.1182/blood-2009-06-225565  PMID:19846889
  • Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D. M., Bussel, J. B., Cines, D. B., Chong, B. H., Cooper, N., Godeau, B., Lechner, K., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood  2009 113:2386-2393  DOI:10.1182/blood-2008-07-162503  PMID:19005182
  • Mathias, S. D., Gao, S. K., Miller, K. L., Cella, D., Snyder, C., Turner, R., Wu, A., Bussel, J. B., George, J. N., McMillan, R., Wysocki, D. K., Nichol, J. L. Impact of chronic immune thrombocytopenic purpura (itp) on health-related quality of life: A conceptual model starting with the patient perspective Health and Quality of Life Outcomes  2008 6:13  DOI:10.1186/1477-7525-6-13  PMID:18261217  PMCID:PMC2275726
  • McMillan, R., Bussel, J. B., George, J. N., Lalla, D., Nichol, J. L. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura American Journal of Hematology  2008 83:150-154  DOI:10.1002/ajh.20992  PMID:17722072
  • Mathias, S. D., Bussel, J. B., George, J. N., McMillan, R., Okano, G. J., Nichol, J. L. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: Psychometric testing in an open-label clinical trial Clinical Therapeutics  2007 29:950-962  DOI:10.1016/j.clinthera.2007.05.005  PMID:17697914
  • Mathias, S. D., Bussel, J. B., George, J. N., McMillan, R., Okano, G. J., Nichol, J. L. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation Health and Quality of Life Outcomes  2007 5:11  DOI:10.1186/1477-7525-5-11  PMID:17316442  PMCID:PMC1808052
  • Bussel, J. B., Kuter, D. J., George, J. N., McMillan, R., Aledort, L. M., Conklin, G. T., Lichtin, A. E., Lyons, R. M., Nieva, J., Wasser, J. S., Wiznitzer, I., Kelly, R., et al. Amg 531, a thrombopoiesis-stimulating protein, for chronic itp New England Journal of Medicine  2006 355:1672-1681  DOI:10.1056/NEJMoa054626  PMID:17050891
  • George, J. N., Woolf, S. H., Raskob, G. E., Wasser, J. S., Aledort, L. M., Ballem, P. J., Blanchette, V. S., Bussel, J. B., Cines, D. B., Kelton, J. G., Lichtin, A. E., McMillan, R., et al. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology Annals of Internal Medicine  1997 126:319-326  DOI:10.7326/0003-4819-126-4-199702150-00010  PMID:9036806
  • George, J. N., Woolf, S. H., Raskob, G. E., Wasser, J. S., Aledort, L. M., Ballem, P. J., Blanchette, V. S., Bussel, J. B., Cines, D. B., Kelton, J. G., Lichtin, A. E., McMillan, R., et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the american society of hematology Blood  1996 88:3-40  PMID:8704187